These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14748795)

  • 21. A plea for C3--the case for the defence.
    Wells C
    Cytopathology; 2003 Aug; 14(4):184-5. PubMed ID: 12873309
    [No Abstract]   [Full Text] [Related]  

  • 22. Granular cell tumor of breast: diagnosis by fine needle aspiration cytology.
    Jayaram G; Hoon PB; Har YC
    Acta Cytol; 2006; 50(5):593-5. PubMed ID: 17017454
    [No Abstract]   [Full Text] [Related]  

  • 23. [European recommendations for quality assurance in the setting of mammographic screening for breast cancer. Report of pathologists of the working group "Breast Cancer Screening" of the European Union].
    Ann Pathol; 1996 Nov; 16(5):315-33. PubMed ID: 9004719
    [No Abstract]   [Full Text] [Related]  

  • 24. [Variations in the diagnostic confirmation process between breast cancer mass screening units].
    Natal C; Fernández-Somoano A; Torá-Rocamora I; Tardón A; Castells X;
    Gac Sanit; 2016; 30(4):265-71. PubMed ID: 27137776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The microscopic complexities of C3 in breast cytology.
    Weigner J; Zardawi I; Braye S; McElduff P
    Acta Cytol; 2014; 58(4):335-46. PubMed ID: 25012460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic help of HER-2/neu expression in suspicious cases of breast fine needle aspiration.
    Umudum H; Rezanko T; Dag F; Dogan M
    Acta Cytol; 2006; 50(5):596-8. PubMed ID: 17017455
    [No Abstract]   [Full Text] [Related]  

  • 27. The accuracy of abnormal cytology report in breast fine needle aspiration alone and in combination with clinical and imaging findings - a hospital based five year study in Kuwait.
    Arora R; El Hameed AA; Al Ajrawi T; Al Harbi O; Elbasmy AA
    Gulf J Oncolog; 2008 Jul; (4):33-8. PubMed ID: 20084773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical and suspicious categories in fine needle aspiration cytology of the breast: histological and mammographical correlation and clinical significance.
    Chaiwun B; Sukhamwang N; Lekawanvijit S; Sukapan K; Rangdaeng S; Muttarak M; Thorner PS
    Singapore Med J; 2005 Dec; 46(12):706-9. PubMed ID: 16308644
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IAC Standardized Reporting of Breast Fine-Needle Aspiration Biopsy Cytology.
    Field AS; Schmitt F; Vielh P
    Acta Cytol; 2017; 61(1):3-6. PubMed ID: 27806362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Breast cancer screening in the Flemish region, Belgium.
    Van Oyen H; Verellen W
    Eur J Cancer Prev; 1994 Jan; 3 Suppl 1():7-12. PubMed ID: 8130728
    [No Abstract]   [Full Text] [Related]  

  • 31. [Needle aspiration cytology of the breast: current perspective on the role in diagnosis and management].
    Kocjan G
    Acta Med Croatica; 2008 Oct; 62(4):391-401. PubMed ID: 19205416
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fine-Needle Aspiration Biopsy Management of the Axilla in Primary Breast Carcinoma.
    Gibbons CE; Quinn CM; Gibbons D
    Acta Cytol; 2019; 63(4):314-318. PubMed ID: 30893685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The cost-effectiveness of fine-needle aspiration cytology and 14-gauge core needle biopsy compared with open surgical biopsy in the diagnosis of breast carcinoma.
    Logan-Young W; Dawson AE; Wilbur DC; Avila EE; Tomkiewicz ZM; Sheils LA; Laczin JA; Taylor AS
    Cancer; 1998 May; 82(10):1867-73. PubMed ID: 9587118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cancer size, histotype, and cellular grade may limit the success of fine-needle aspiration cytology for screen-detected breast carcinoma.
    Manfrin E; Falsirollo F; Remo A; Reghellin D; Mariotto R; Dalfior D; Piazzola E; Bonetti F
    Cancer; 2009 Dec; 117(6):491-9. PubMed ID: 19806645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Core needle biopsy rate for new cancer diagnosis in an interdisciplinary breast center: evaluation of quality of care 2007-2008.
    Linebarger JH; Landercasper J; Ellis RL; Gundrum JD; Marcou KA; De Maiffe BM; Hudak JM; Andersen JJ
    Ann Surg; 2012 Jan; 255(1):38-43. PubMed ID: 22167007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma.
    Lieske B; Ravichandran D; Wright D
    Br J Cancer; 2006 Jul; 95(1):62-6. PubMed ID: 16755293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive power of cytomorphological features in equivocal (C3, C4) breast FNAC.
    Moyes C; Dunne B
    Cytopathology; 2004 Dec; 15(6):305-10. PubMed ID: 15606362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic Value of Fine Needle Aspiration Cytology for Breast Tumors.
    Mišković J; Zorić A; Radić Mišković H; Šoljić V
    Acta Clin Croat; 2016 Dec; 55(4):625-628. PubMed ID: 29117654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cost-effectiveness of image-guided core needle biopsy versus surgery in diagnosing breast cancer.
    Nields MW
    Acad Radiol; 1996 Apr; 3 Suppl 1():S138-40. PubMed ID: 8796544
    [No Abstract]   [Full Text] [Related]  

  • 40. Mammography facilities must meet quality standards.
    Segal M
    FDA Consum; 1994 Mar; 28(2):8-12. PubMed ID: 10132985
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.